HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model.

Abstract
High level galectin-1 expression results in cancer cell evasion of the immune response, increased tumour survival and aggressive metastases. Using a galectin-1 polyclonal antibody, high levels of galectin-1 protein were shown to be expressed by breast cancer cells established from FVB/N MMTV-c-neu mice as well as by the B16F10 melanoma cell line. In mixed lymphocyte cultures using tumour cells as antigenic stimulators, addition of recombinant galectin-1 dose-dependently inhibited lymphocyte production. Disaccharides were identified that inhibited galectin-1 function and increased growth and activation of CD8(+) CTL's killing cancer cells. X-ray crystallographic structures of human galectin-1 in complex with inhibitory disaccharides revealed their mode of binding. Combining galectin-blocking carbohydrates as adjuvants with vaccine immunotherapy in vivo to promote immune responses significantly decreased tumour progression and improved the outcomes for tumour challenged mice. This is the first report showing that suitably selected galectin-1 blocking disaccharides will act as adjuvants promoting vaccine stimulated immune responses against tumours in vivo.
AuthorsKimberley A Stannard, Patrick M Collins, Koichi Ito, Emily M Sullivan, Stacy A Scott, Elwyn Gabutero, I Darren Grice, Pauline Low, Ulf J Nilsson, Hakon Leffler, Helen Blanchard, Stephen J Ralph
JournalCancer letters (Cancer Lett) Vol. 299 Issue 2 Pg. 95-110 (Dec 28 2010) ISSN: 1872-7980 [Electronic] Ireland
PMID20826047 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCrown Copyright © 2010. Published by Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Cancer Vaccines
  • Disaccharides
  • Galectin 1
  • Galectin 3
  • Galectins
  • Thiogalactosides
  • lactobionic acid
Topics
  • Animals
  • Blotting, Western
  • CD8-Positive T-Lymphocytes (immunology)
  • Cancer Vaccines (administration & dosage, immunology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Crystallography, X-Ray
  • Cytotoxicity, Immunologic (drug effects)
  • Disaccharides (chemistry, metabolism, pharmacology)
  • Female
  • Galectin 1 (chemistry, genetics, metabolism)
  • Galectin 3 (chemistry, genetics, metabolism)
  • Galectins (chemistry, genetics, metabolism)
  • Humans
  • Immunity (drug effects)
  • Immunotherapy (methods)
  • Mammary Neoplasms, Experimental (immunology, pathology, therapy)
  • Mice
  • Mice, Inbred Strains
  • Models, Molecular
  • Protein Binding
  • Thiogalactosides (chemistry, metabolism, pharmacology)
  • Tumor Burden (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: